ResearcherEhime UniversityActive in the last 2 years
Akimasa Sakamoto
Matched on ORCID iD 0000-0001-8042-1486; OpenAlex author ID A5058550077. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers
Papers 8
- Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study. Co-author DOI 10.1038/s41598-025-02365-5↗
- Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curative Surgery for Pancreatic Ductal Adenocar… First author DOI 10.3390/cancers17091448↗
- Nutritional Status and Chemotherapy Completion in Resectable Pancreatic Cancer: A Narrative Review. Co-author DOI 10.3390/curroncol32090519↗
- C-Reactive Protein-to-Albumin Ratio to Predict Tolerability of S-1 as an Adjuvant Chemotherapy in Pancreatic Cancer. First author DOI 10.3390/cancers16050922↗
- C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy after Curative Surgery for Pancreatic Ca… Co-author DOI 10.3390/cancers16193372↗
- Geriatric Nutritional Risk Index Predicts Tolerability of S-1 as Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002240↗
- Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study. First author DOI 10.1038/s41598-022-18077-z↗
- Association between the Preoperative C-Reactive Protein-to-Albumin Ratio and the Risk for Postoperative Pancreatic Fistula following Distal Pancreatectomy for … Co-author DOI 10.3390/nu14245277↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Naotake Funamizu · 8 shared papers, 2022–2025 · strength 1.59
- Paper Nutritional Status and Chemotherapy Completion in Resectable Pancreatic Cancer: A Narrative Review. DOI 10.3390/curroncol32090519↗
- Paper Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual cen… DOI 10.1038/s41598-025-02365-5↗
- Paper Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curativ… DOI 10.3390/cancers17091448↗
- Yasutsugu Takada · 7 shared papers, 2022–2025 · strength 1.31
- Paper Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual cen… DOI 10.1038/s41598-025-02365-5↗
- Paper Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curativ… DOI 10.3390/cancers17091448↗
- Paper C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy … DOI 10.3390/cancers16193372↗
- Yuzo Umeda · 4 shared papers, 2024–2025 · strength 0.95
- Paper Nutritional Status and Chemotherapy Completion in Resectable Pancreatic Cancer: A Narrative Review. DOI 10.3390/curroncol32090519↗
- Paper Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual cen… DOI 10.1038/s41598-025-02365-5↗
- Paper Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curativ… DOI 10.3390/cancers17091448↗
- Taku Aoki · 3 shared papers, 2024–2025 · strength 0.66
- Paper Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual cen… DOI 10.1038/s41598-025-02365-5↗
- Paper Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curativ… DOI 10.3390/cancers17091448↗
- Paper C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy … DOI 10.3390/cancers16193372↗
- Takeshi Utsunomiya · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.